Detection Test By Nucleic Acid For Digestive Tract Pathogen, Multiple Types Or Subtypes, 3-5 Targets in South Carolina
Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.
Top Providers in South Carolina
| Provider | Medicare | Services |
|---|---|---|
| Luxor Scientific, Llc | $125.72 | 32 |
| Vikor Scientific, Llc | $125.72 | 20 |
South Carolina Pricing in Context
In South Carolina, CPT code 87505 (Detection Test By Nucleic Acid For Digestive Tract Pathogen, Multiple Types Or Subtypes, 3-5 Targets) carries an average Medicare payment of $125.72 — 1% above the national benchmark of $124.77. 3 providers across the state submitted claims for this procedure in 2023, performing 54 total services. Individual payments in SC ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.
The average billed charge in South Carolina is $162.50, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because South Carolina sits above the national Medicare average, commercial rates in the state may also run higher than the US median.
Using RAND 2024 commercial-to-Medicare ratios for Laboratory procedures, the estimated commercial insurance price in South Carolina lands near $295.44, with self-pay cash prices typically around $138.98. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.
Frequently Asked Questions
How much does Detection Test By Nucleic Acid For Digestive Tract Pathogen, Multiple Types Or Subtypes, 3-5 Targets cost in South Carolina?
The average Medicare payment for Detection Test By Nucleic Acid For Digestive Tract Pathogen, Multiple Types Or Subtypes, 3-5 Targets in South Carolina is $125.72, which is 1% above the national average of $124.77. Providers in SC typically bill $162.50 for this procedure.
What does Detection Test By Nucleic Acid For Digestive Tract Pathogen, Multiple Types Or Subtypes, 3-5 Targets cost with insurance in South Carolina?
With commercial insurance in South Carolina, Detection Test By Nucleic Acid For Digestive Tract Pathogen, Multiple Types Or Subtypes, 3-5 Targets costs an estimated $295.44. Without insurance, the estimated cash price is $138.98. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.
How many providers perform Detection Test By Nucleic Acid For Digestive Tract Pathogen, Multiple Types Or Subtypes, 3-5 Targets in South Carolina?
3 providers in South Carolina billed Medicare for Detection Test By Nucleic Acid For Digestive Tract Pathogen, Multiple Types Or Subtypes, 3-5 Targets in 2023, performing 54 total services. Medicare payments ranged from N/A to N/A depending on the provider.
Is Detection Test By Nucleic Acid For Digestive Tract Pathogen, Multiple Types Or Subtypes, 3-5 Targets cheaper in South Carolina than the national average?
No — Detection Test By Nucleic Acid For Digestive Tract Pathogen, Multiple Types Or Subtypes, 3-5 Targets costs 1% above the national average in South Carolina. The state average Medicare payment is $125.72 compared to $124.77 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.
Related Guides
Related Data Sources
Data from CMS Medicare Physician & Other Practitioners (2023).
Read our methodology — how this data is sourced, computed, and verified.